Audit Committee Position

Hadley Ford

CEO and Director

Hadley Ford is a healthcare and technology industry veteran with more than 20 years of experience as both an operating executive and investment banker. Mr. Ford has extensive experience in all operational facets of managing a large, world-class patient-centric healthcare operation. From 2005 to 2013, Mr. Ford was the co-founder and CEO of ProCure Treatment Centers, Inc., developer and operator of full-service proton therapy centers for the treatment of cancer. From ProCure’s inception, Mr. Ford grew the company to over 300 employees and $100 million of annual revenue. Prior to ProCure, Mr. Ford spent fourteen years on Wall Street with First Boston, Bank of America and Goldman Sachs, where he completed over 150 transactions worth billions of dollars for all size clients in multiple industries.


Julius Kalcevich

Chief Financial Officer and Director

Mr. Kalcevich has over 15 years of experience in corporate finance and strategic consulting.  Previously a partner of BG Partners Corp. in Toronto, Canada, he was responsible for planning, structuring and monitoring corporate finance transactions for his firm’s cannabis investments.  Mr. Kalcevich was previously a Director of Investment Banking with CIBC World Markets and Oppenheimer in Toronto and New York. During the period of 2005-2012, he completed over 20 transactions representing over $4 billion in aggregate value.  Mr Kalcevich is a graduate of McGill University (B.A. 1997) and Columbia University (M.B.A. 2005).


Paul Rosen


Paul Rosen is a founder of PharmaCan Capital Corporation, a publicly traded merchant bank focused on investing in Canada’s medical marijuana industry. Mr. Rosen served as President and CEO of PharmaCan Capital for three years. While CEO at PharmaCan, Mr. Rosen executed the successful purchase of In The Zone Produce Ltd (“ITZ”), a Canadian medical marijuana producer licensed by Health Canada following which he concurrently served as President and the Senior Person in Charge (SPIC) at ITZ. An SPIC is the executive required by Health Canada to exercise overall responsibility for management of all regulated activities carried out by the licensed producer at its site. Prior to founding PharmaCan, Mr. Rosen founded and served as CEO of Skypad Inc. (“Skypad”), a leading global contract manufacturer. Mr. Rosen currently serves as Skypad’s Chairman.